DRIO - DarioHealth Corp.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
0.4390
+0.0086 (+2.00%)
As of 9:53AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.4304
Open0.4390
Bid0.4350 x 1000
Ask0.4587 x 900
Day's Range0.4300 - 0.4390
52 Week Range0.3610 - 1.4200
Volume14,969
Avg. Volume119,958
Market Cap16.684M
Beta (3Y Monthly)0.44
PE Ratio (TTM)N/A
EPS (TTM)-0.7190
Earnings DateMar 20, 2019 - Mar 22, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.83
Trade prices are not sourced from all markets
  • PR Newswire15 days ago

    DarioHealth Granted 180-day Extension by Nasdaq to Regain Compliance With bid Price Rule

    NEW YORK and CAESAREA, Israel, July 8, 2019 /PRNewswire/ -- Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO) today announced that on July 5, 2019, it received notification from Nasdaq that the Company has been granted an additional 180-day compliance period, or until December 23, 2019, to regain compliance with the minimum $1.00 bid price per share requirement of Nasdaq's Marketplace Rule 5550(a)(2) (the "Rule"). Nasdaq's determination to grant the additional 180-day compliance period was based on the Company meeting the continued listing requirement for the market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market with the exception of the bid price requirement, and the Company having provided written notice of its intention to cure the deficiency during the second compliance period, including effecting a reverse stock split if necessary.

  • DarioHealth Reports Improvement in Glycemic Outcomes With Key Diabetes Findings at the American Diabetes Association's 79th Scientific Sessions
    PR Newswirelast month

    DarioHealth Reports Improvement in Glycemic Outcomes With Key Diabetes Findings at the American Diabetes Association's 79th Scientific Sessions

    SAN FRANCISCO, June 11, 2019 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global Digital Therapeutics (DTx) company with connected devices, mobile software and large data solutions presented two studies reporting new real-world results at the American Diabetes Association's (ADA) 79th Scientific Sessions in San Francisco, California. The studies provide additional insights on how the use of Dario's mobile applications, within a complete digital therapeutics solution, may promote behavioral modifications and enhanced individual engagement with diabetes management.

  • DarioHealth Signs New Functional Medicine Clinic to Its Digital Diabetes Platform
    PR Newswire2 months ago

    DarioHealth Signs New Functional Medicine Clinic to Its Digital Diabetes Platform

    NEW YORK, CAESAREA, Israel and FORT COLLINS, Colorado, June 4, 2019 /PRNewswire/ -- Global #digitaltherapeutics innovator DarioHealth Corp. (DRIO) today announced an agreement with Functional Medicine Center of Fort Collins, based in Fort Collins, CO (https://functionalmedicinefortcollins.com/).

  • DarioHealth to Present New Evidence of Digital Therapeutics Benefits at 2019 American Diabetes Association Conference
    PR Newswire2 months ago

    DarioHealth to Present New Evidence of Digital Therapeutics Benefits at 2019 American Diabetes Association Conference

    NEW YORK and CAESAREA, Israel, May 29, 2019 /PRNewswire/ -- Global digital therapeutics (DTx) innovator, DarioHealth Corp. (DRIO), today announced its participation at the annual conference of the American Diabetes Association (ADA) in San Francisco on June 7th-10th. At the ADA conference, Dario will publish several studies performed using de-identified data from thousands of users accumulated in its data base. The studies demonstrate the benefits of Dario's DTx solution to help improve life with diabetes and achieve clinically proven results.

  • Do Institutions Own DarioHealth Corp. (NASDAQ:DRIO) Shares?
    Simply Wall St.2 months ago

    Do Institutions Own DarioHealth Corp. (NASDAQ:DRIO) Shares?

    Every investor in DarioHealth Corp. (NASDAQ:DRIO) should be aware of the most powerful shareholder groups. Large...

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of DRIO earnings conference call or presentation 13-May-19 1:00pm GMT

    Q1 2019 DarioHealth Corp Earnings Call

  • DarioHealth Corp. Announces Pricing of $7.2 Million Public Offering of Common Stock
    PR Newswire2 months ago

    DarioHealth Corp. Announces Pricing of $7.2 Million Public Offering of Common Stock

    CAESAREA, Israel, May 22, 2019 /PRNewswire/ -- DarioHealth Corp. (DRIO) ("DarioHealth" or the "Company"), a global digital therapeutics innovator, today announced the pricing of an underwritten public offering of 4,855,341 shares of common stock at a price to the public of $0.60 per share and pre-funded warrants to purchase 7,175,525 shares of common stock at a price to the public of $0.5999 per pre-funded warrant for aggregate gross proceeds of approximately $7,200,000, before underwriting discounts and offering expenses. The pre-funded warrants have an exercise price of $0.0001 and are immediately exercisable until exercised in full and include a beneficial ownership blocker of 9.99%. The offering is expected to close on or about May 24, 2019, subject to the satisfaction of customary closing conditions.

  • DarioHealth Corp. Announces Commencement of Public Offering of Common Stock
    PR Newswire2 months ago

    DarioHealth Corp. Announces Commencement of Public Offering of Common Stock

    CAESAREA, Israel, May 21, 2019 /PRNewswire/ -- DarioHealth Corp. (DRIO) ("DarioHealth" or the "Company"), a global digital therapeutics innovator, today announced that it intends to offer and sell shares of common stock (or pre-funded warrants in lieu thereof) in an underwritten public offering. Craig-Hallum Capital Group is acting as sole managing underwriter for the offering.

  • DarioHealth Reports Record Results For First Quarter 2019
    PR Newswire2 months ago

    DarioHealth Reports Record Results For First Quarter 2019

    - Earnings and business update call scheduled for 9:00 am ET today - Record Q1 revenues of $2.2 million , representing 32% sequential revenue growth over 4Q 2018 - Record Q1 billings of $2.8 million (non-GAAP), ...

  • DarioHealth to Host First Quarter 2019 Conference Call May 13, 2019
    PR Newswire3 months ago

    DarioHealth to Host First Quarter 2019 Conference Call May 13, 2019

    Earnings Discussion and Business Update Scheduled for 9:00 am EDT NEW YORK and CAESAREA, Israel , May 7, 2019 /PRNewswire/ -- Global digital therapeutics innovation leader DarioHealth Corp.  (NASDAQ: DRIO) ...

  • DarioHealth Announces New Partnership With the American Diabetes Association
    PR Newswire3 months ago

    DarioHealth Announces New Partnership With the American Diabetes Association

    DarioHealth's mission is to support people with diabetes and other chronic conditions in the U.S. and around the world. ARLINGTON, Virginia, NEW YORK and CAESAREA, Israel, May 3, 2019 /PRNewswire/ -- Global digital therapeutics innovator, DarioHealth Corp. (DRIO), today announced that it is partnering with the American Diabetes Association as a Living Red Sponsor of NYC - Step Out®: Walk to Stop Diabetes®.

  • DarioⓇ Becomes a Member of the Digital Therapeutics Alliance
    PR Newswire3 months ago

    DarioⓇ Becomes a Member of the Digital Therapeutics Alliance

    WASHINGTON and CAESAREA, Israel, April 30, 2019 /PRNewswire/ -- Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced that it is now a member of the Digital Therapeutics Alliance (DTA) (www.DTxAlliance.org). Dario's acceptance to the DTA as a new member demonstrates its commitment to the core principles of the DTA - encouraging data-driven integration and utilization of digital therapeutics across the healthcare industry, engaging patients and enabling healthcare providers to intelligently manage and expand the delivery and quality of patient care, optimizing clinical treatment pathways, enhancing patient outcomes, increasing overall healthcare value and educating patients, providers, payers, and other healthcare industry stakeholders, on the value and improved health outcomes delivered through digital therapeutics.

  • Dario® Elevates Digital Therapeutics Capabilities by Further Enhancing Patient Experience
    PR Newswire3 months ago

    Dario® Elevates Digital Therapeutics Capabilities by Further Enhancing Patient Experience

    New version V4.2.0 is a testament to Dario's relentless commitment to patients with chronic conditions. CAESAREA, Israel, April 10, 2019 /PRNewswire/ -- Global digital therapeutics innovator, DarioHealth Corp. (DRIO), today announced the launch of a new version of its acclaimed Dario® system and DarioEngage™ platform. The Company's first goal is driving ever stronger user engagement by implementing a more intuitive and personalized experience in the individual user application as well as in the coaching platform.

  • DarioHealth Signs Leading Functional Medicine Clinic to DarioEngage™ Remote Digital Diabetes Platform
    PR Newswire4 months ago

    DarioHealth Signs Leading Functional Medicine Clinic to DarioEngage™ Remote Digital Diabetes Platform

    NEW YORK and CAESAREA, Israel, April 1, 2019 /PRNewswire/ -- Global #digitaltherapeutics innovator DarioHealth Corp. (DRIO) today announced an agreement with Cupertino-based Auer Integrative Health's Functional Medicine and Chiropractic, a Silicon Valley medical clinic. Auer Integrative, a leader in the U.S., will use the DarioEngage™ healthcare provider platform from DarioHealth to remotely monitor, engage and manage patients with diabetes and pre-diabetes. DarioHealth sees clinics as ideal partners to scale up its growth and deliver tangible medical outcomes while providing users with the outstanding experience of diabetes support and lifestyle coaching from their healthcare provider.

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of DRIO earnings conference call or presentation 25-Mar-19 1:00pm GMT

    Q4 2018 DarioHealth Corp Earnings Call

  • DarioHealth Partners With Glytec on Outpatient Diabetes Management
    PR Newswire4 months ago

    DarioHealth Partners With Glytec on Outpatient Diabetes Management

    CAESAREA, Israel and WALTHAM, Massachusetts, March 27, 2019 /PRNewswire/ -- Global digital therapeutics innovator, DarioHealth Corp. (DRIO), today announced a joint marketing agreement with Glytec, the market leader and pioneer of insulin titration solutions for use across the full continuum of care. The agreement allows DarioHealth's smart glucose meter (part of the Dario Blood Glucose Monitoring System) to transmit information to Glytec's Glucommander™ Outpatient software-as-a-medical-device.

  • DarioHealth Reports Fourth Quarter and Year End 2018 Record Results
    PR Newswire4 months ago

    DarioHealth Reports Fourth Quarter and Year End 2018 Record Results

    Conference Call Scheduled for 9:00 am ET today CAESAREA, Israel , March 25, 2019 /PRNewswire/ -- Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today reported record financial ...

  • DarioHealth Granted License by Health Canada to Sell Dario Smart Glucose Meters for Lightning® Connector Enabled iPhones
    PR Newswire4 months ago

    DarioHealth Granted License by Health Canada to Sell Dario Smart Glucose Meters for Lightning® Connector Enabled iPhones

    NEW YORK and CAESAREA, Israel, March 20, 2019 /PRNewswire/ -- Global digital therapeutics innovator, DarioHealth Corp. (DRIO), announced today the receipt of a license from Health Canada to sell its Dario™ Blood Glucose Monitoring System for Lightning power connector-enabled iPhone smart mobile devices. DarioHealth has marketed the product in Canada exclusively for Apple iOS 6.1 platform and higher, and for leading Android devices since receiving a license from Health Canada in May 2015. With this license, DarioHealth's addressable Canadian market expands to include the entire iPhone user base.

  • DarioHealth to Host Fourth Quarter and Year End 2018 Conference Call March 25, 2019
    PR Newswire4 months ago

    DarioHealth to Host Fourth Quarter and Year End 2018 Conference Call March 25, 2019

    Earnings Discussion and Business Update Scheduled for 9:00 am EDT NEW YORK and CAESAREA, Israel , March 18, 2019 /PRNewswire/ -- Global digital therapeutics innovation leader DarioHealth Corp.  (NASDAQ: ...

  • DarioHealth Signs National Distribution Deal in the U.S. With Better Living Now for Its Digital Health Products
    PR Newswire7 months ago

    DarioHealth Signs National Distribution Deal in the U.S. With Better Living Now for Its Digital Health Products

    NEW YORK and CAESAREA, Israel, Jan. 2, 2019 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has signed an agreement with Better Living Now (BLN), a leading national healthcare products provider, for distribution of the Dario® Blood Glucose Monitoring System and the DarioEngage digital health platform. BLN will purchase DarioHealth's products including the Dario smart glucose meter and test strips for distribution to its customers, as well as offer a full diabetes management program including coaching through DarioEngage on a monthly subscription basis.

  • Simply Wall St.7 months ago

    What Did DarioHealth Corp.’s (NASDAQ:DRIO) CEO Take Home Last Year?

    Erez Raphael has been the CEO of DarioHealth Corp. (NASDAQ:DRIO) since 2013. First, this article will compare CEO compensation with compensation at similar sized companies. Then we'll look at a Read More...

  • DarioHealth to Offer Diabetes Content and Coaching to Patients in Canada in Collaboration With LMC Healthcare, Canada's Largest Diabetes and Endocrinology Specialist Care Provider
    PR Newswire7 months ago

    DarioHealth to Offer Diabetes Content and Coaching to Patients in Canada in Collaboration With LMC Healthcare, Canada's Largest Diabetes and Endocrinology Specialist Care Provider

    CAESAREA, Israel, Dec. 12, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Toronto-based LMC Healthcare, Canada's largest specialist care provider in diabetes and endocrinology, will work with Dario who will provide digital content and coaching services  across Canada for patients with diabetes. LMC has 11 clinics and 19 clinical research sites that provide care to over 39,000 patients with diabetes in Canada.

  • DarioHealth's Diabetes Digital Health Solution Now Available at Best Buy
    PR Newswire8 months ago

    DarioHealth's Diabetes Digital Health Solution Now Available at Best Buy

    CAESAREA, Israel, Nov. 14, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that the Dario Blood Glucose Monitor has been included in Best Buy's growing portfolio of digital healthcare services and products. The Dario Blood Glucose Monitor is part of DarioHealth's complete platform, which includes the Dario App and DarioEngage patient management system.

  • DarioHealth Reports Third Quarter 2018 Results
    PR Newswire8 months ago

    DarioHealth Reports Third Quarter 2018 Results

    - Earnings and business update call scheduled for 9:00 am ET today - Revenues in first 9 months grow to $5.7 million , a 58% increase year over year - Q3 revenues grow to $1.88 million , a 37% increase ...

  • DarioHealth's Digital Diabetes Platform to be Made Available to 4.6 Million Customers at Giant Eagle, One of America's Largest Supermarket Chains
    PR Newswire8 months ago

    DarioHealth's Digital Diabetes Platform to be Made Available to 4.6 Million Customers at Giant Eagle, One of America's Largest Supermarket Chains

    Millions of Customers Will Be Able to Sign Up for Online Education and Rewards through the DarioHealth Blood Glucose Monitoring System and Smartphone Application. CAESAREA, Israel, Nov. 12, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has signed an agreement for the rollout of a Digital Diabetes Education and Rewards Program, powered by Dario, to Giant Eagle's consumers through the pharmacy's 214 locations. Giant Eagle is ranked among the top 40 on Forbes magazine's list of largest private corporations in the U.S. It is one of the country's largest food retailers and distributors with approximately $8.9 billion in annual sales.